By

Protect Access and Innovation
New Digital Ad Campaign to Elevate Patient Voices through Video Testimonial Series, New ‘Protect Access and Innovation’ Web Hub and Advocacy Launchpad Sacramento & San Francisco CA & Washington, DC (August 16, 2018) – California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, today announced the launch of “Faces of California...
Read More
Dad of two, Vance Sharp III survived congestive heart failure thanks to biomedical innovations in California! @CALifeSciences #FacesOfCABiomedicalInnovation
Read More
Evaleen Minez Harris was diagnosed with #cardiomyopathy right after the birth of her twins. Thanks to her #LVAD #Heartmate3 and California's biomedical industry she's here today. Read Evaleen's powerful story here: https://protectaccessandinnovation.org/faces-california-biomedical-innovation-mother-two-evaleen-minez-harris-survives-peripartum-cardiomyopathy-thanks-california-made-medical-device
Read More
Deborah Goldberg was diagnosed with colorectal #cancer 4 years ago. Deborah and her family are thankful for the innovative and life-saving treatments developed by California’s biomedical community. Treatments that saved her life. #FacesOfCABiomedicalInnovation @CALifeSciences
Read More
Thanks to California’s biomedical industry, Jeff Finerman beat cancer and is alive today. California policymakers should protect this life saving industry and not pass short-sighted policies that could harm innovation or R&D. #FacesOfCABiomedicalInnovation @CALifeSciences
Read More
Check out the infographic below to learn who the real money-makers in healthcare are:
Read More
By Dan Leonard Chain Drug Review April 27th, 2018 One of the great paradoxes in medicine today is the reality that drug prices are rising at the lowest level in years, yet both patients and employers are feeling more of a squeeze on drug costs than ever before. Ironically both of these trends — slowing...
Read More
By Sydney Lupkin Kaiser Health News  March 13, 2018   As a health economist, Karen Van Nuys had heard that it’s sometimes cheaper to pay cash at the pharmacy counter than to put down your insurance card and pay a copay. So one day, she asked her pharmacist how much her prescription would cost if she...
Read More
By Reed Abelson The New York Times March 6, 2018 In response to growing consumer frustration over drug prices, UnitedHealthcare, one of the nation’s largest health insurers, said on Tuesday that it would stop keeping millions of dollars in discounts it gets from drug companies and share them with its customers. Dan Schumacher, the president of...
Read More
By Robert Pear The New York Times February 24, 2018 WASHINGTON — As consumers face rapidly rising drug costs, states across the country are moving to block “gag clauses” that prohibit pharmacists from telling customers that they could save money by paying cash for prescription drugs rather than using their health insurance. Many pharmacists have expressed...
Read More
By Casey Ross StatNews February 16, 2018 As Washington’s interest in drug prices has spiked in recent years, a largely invisible industry has suddenly found itself in the spotlight. Pharmacy benefit managers, or PBMs, are the middlemen who stand between manufacturers and consumers in the nation’s drug business. And they’ve been blamed by pharma companies for...
Read More
1 2 3